Mirum Pharmaceuticals Director Laura Brege Sells $1.33 Million in Common Shares

• Mirum Pharmaceuticals director Laura Brege sold 14,167 common shares on Nov. 11, 2026.
• Sales comprised 10,907 shares at $94.05 per share and 3,260 shares at $94.74 per share.
• Brege also exercised stock options to acquire 14,167 common shares at $16.71 per share.
• Her direct common stock holdings totaled 15,703 shares following the transactions, disclosed in a Form 4 dated Nov. 13, 2026.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Mirum Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001365619-26-000007), on November 13, 2026, and is solely responsible for the information contained therein.